How Common Is a Klebsiella UTI and How Is It Treated?

Klebsiella pneumoniae is one of the most common bacteria behind urinary tract infections, second only to E. coli. It causes UTIs in both everyday community settings and in hospitals, where it tends to be even more problematic because of antibiotic resistance. Treatment usually involves antibiotics chosen based on lab testing, but the growing number of drug-resistant Klebsiella strains has made some of these infections genuinely difficult to treat.

How Common Klebsiella UTIs Actually Are

Most people associate UTIs with E. coli, and for good reason: E. coli is responsible for the majority of them. But Klebsiella pneumoniae is consistently the next most frequent culprit, playing a significant role in both infections people pick up in daily life and those acquired in healthcare settings.¹ In hospitals and long-term care facilities, Klebsiella becomes an even bigger player, partly because the people in those settings tend to have weakened immune systems and partly because the bacteria thrives in environments where catheters and medical devices are common.

What makes Klebsiella stand out from many other UTI-causing bacteria is its versatility. It is not just an opportunistic germ that takes advantage of sick patients in hospitals. It causes plenty of infections in otherwise healthy people too, though those infections tend to be more straightforward to treat. The hospital-acquired variety is what keeps infectious disease specialists up at night, because those strains are far more likely to resist the antibiotics doctors reach for first.

Who Gets Klebsiella UTIs

Anyone can develop a Klebsiella UTI, but certain groups face a much higher risk. The biggest risk factors include advanced age, diabetes, cancer, chronic lung disease, a weakened immune system, recent antibiotic use, long hospital stays, having a urinary catheter in place, and any procedure involving the urinary tract.²

Several of those risk factors overlap in obvious ways. A person hospitalized for cancer treatment, for instance, might be immunosuppressed, on antibiotics, and catheterized all at once. Each of those conditions independently raises the chance of a Klebsiella UTI, so when they stack up, the risk climbs steeply. Diabetes deserves special attention here because it is extremely common and often underestimated as a UTI risk factor. High blood sugar impairs the immune system’s ability to fight off bacteria, and people with diabetes are also more prone to incomplete bladder emptying, which gives bacteria more time to multiply.

Prior antibiotic exposure is another risk factor worth understanding. When you take antibiotics for any reason, you wipe out some of the normal bacteria that keep opportunistic germs like Klebsiella in check. This opens the door for Klebsiella to colonize and eventually cause an infection. It is a frustrating cycle: the very drugs meant to fight infections can set the stage for new ones.

Urinary catheters are probably the single most direct route for Klebsiella to reach the bladder. The catheter provides a physical surface that bacteria can latch onto and use as a highway into the urinary tract. The longer a catheter stays in, the higher the risk. This is why hospital infection-control teams push hard to remove catheters as soon as they are no longer medically necessary.

What a Klebsiella UTI Feels Like

Symptom-wise, a Klebsiella UTI looks a lot like any other bacterial UTI. You get the familiar burning during urination, the constant urge to go even when the bladder is nearly empty, cloudy or strong-smelling urine, and sometimes pelvic pain or pressure. If the infection stays in the lower urinary tract (the bladder and urethra), these symptoms are annoying but manageable.

The concern with Klebsiella is that it has a somewhat higher tendency to cause complicated infections compared to some other UTI bacteria. A “complicated” UTI in medical terms does not just mean a bad one. It means the infection involves an abnormal urinary tract, a catheter, or has spread beyond the bladder. When Klebsiella climbs to the kidneys, symptoms shift: fever, chills, flank pain, nausea, and sometimes vomiting. In rare and severe cases, Klebsiella can cause a condition called emphysematous cystitis, where gas forms in the bladder wall, or emphysematous pyelonephritis, where gas forms in the kidneys. Catching these complications early is critical because they can progress to urosepsis, a life-threatening bloodstream infection.³

Older adults and people with diabetes are particularly vulnerable to these severe complications, and their symptoms can be misleading. An elderly patient with a Klebsiella UTI might not have the classic burning or urgency at all. Instead, they may present with confusion, general weakness, or abdominal pain that does not immediately point toward a urinary infection. If you are caring for someone elderly who suddenly becomes confused or lethargic, a UTI is one of the things that should be on the radar.

How Standard Klebsiella UTIs Are Treated

For a straightforward, uncomplicated Klebsiella UTI, treatment follows the same general approach as other bacterial UTIs: a course of antibiotics guided by a urine culture and sensitivity test. The culture identifies which bacteria are causing the infection, and the sensitivity test tells the doctor which antibiotics that particular strain responds to. This step matters more with Klebsiella than with many E. coli infections because Klebsiella is naturally resistant to certain common antibiotics like ampicillin and amoxicillin. Starting one of those drugs empirically, before culture results come back, would be a wasted effort against most Klebsiella strains.

When the strain is susceptible, doctors typically use antibiotics like trimethoprim-sulfamethoxazole, nitrofurantoin (for lower UTIs only), or a fluoroquinolone like ciprofloxacin. For more complicated infections that have reached the kidneys or entered the bloodstream, treatment usually shifts to intravenous antibiotics such as a third-generation cephalosporin or a carbapenem, depending on what the lab results show.

The duration of treatment varies. A simple lower UTI might need only three to seven days of oral antibiotics. A kidney infection or complicated UTI generally calls for a longer course, sometimes ten to fourteen days, and often starts in the hospital with IV drugs before switching to pills once improvement is clear. Your doctor’s choice of drug and duration will hinge almost entirely on what the culture shows, so providing a urine sample before starting antibiotics is genuinely important, even if you are eager to start treatment.

The Drug Resistance Problem

This is where Klebsiella UTIs diverge sharply from the typical UTI experience. Klebsiella pneumoniae has a well-documented ability to develop resistance to antibiotics, and the most alarming strains are those that produce enzymes called carbapenemases. These enzymes break down carbapenems, which are often considered last-resort antibiotics for serious infections. The rise of carbapenemase-producing Klebsiella has been reported worldwide, and most of these resistant infections occur in hospital settings.⁴

The stakes with these resistant strains are high. Serious infections caused by carbapenemase-producing Klebsiella can be fatal in roughly half of reported cases.⁴ That number reflects the overall picture of serious carbapenemase-producing Klebsiella infections, not UTIs specifically, but it underscores why resistance matters so much. A UTI caused by one of these strains cannot be treated with the usual antibiotic toolbox, and if it spreads to the bloodstream, the available options narrow dramatically.

For UTIs caused by carbapenemase-producing Klebsiella, newer antibiotics have become essential. These include drugs like cefiderocol, meropenem combined with vaborbactam, ceftazidime combined with avibactam, and imipenem-cilastatin combined with relebactam. Treatment courses for complicated UTIs with these drugs typically run five to ten days, with doses given intravenously every six to eight hours depending on the specific drug and the patient’s kidney function.⁵ These are hospital-only medications, administered under close medical supervision. They represent genuine therapeutic advances, but they are expensive, require IV access, and are reserved for infections where older antibiotics have failed or cannot work.

Extended-spectrum beta-lactamase (ESBL) producing Klebsiella is another category of resistant strains that falls between ordinary Klebsiella and the carbapenemase producers in terms of severity. ESBL strains resist many common antibiotics like cephalosporins but still respond to carbapenems. This intermediate level of resistance is actually more common than carbapenemase production and is increasingly seen in community settings, not just hospitals. If your urine culture comes back showing an ESBL-producing Klebsiella strain, your doctor will likely prescribe a carbapenem or one of the newer combination drugs, depending on the exact resistance pattern.

Why Klebsiella Is Harder to Clear Than E. Coli

Beyond resistance genes, Klebsiella pneumoniae has structural advantages that make it a stubborn pathogen. The bacterium has a thick polysaccharide capsule surrounding it, which acts like a shield against the immune system. This capsule makes it harder for white blood cells to engulf and destroy the bacteria. Klebsiella also produces biofilms, which are thin, slimy layers of bacteria that adhere to surfaces like catheter tubing or the bladder wall. Bacteria living inside a biofilm are significantly harder for antibiotics to reach, which is one reason catheter-associated Klebsiella UTIs can be so persistent.

These biological features help explain why Klebsiella UTIs sometimes recur or fail to clear with the first course of antibiotics. If you have been treated for a Klebsiella UTI and your symptoms come back shortly after finishing antibiotics, it does not necessarily mean the antibiotics were wrong. It may mean the bacteria were hiding in a biofilm and re-emerged once antibiotic pressure dropped. A repeat culture and possibly a longer or different antibiotic course is the standard approach in that situation.

Preventing Klebsiella UTIs

For people outside the hospital, the prevention advice for Klebsiella UTIs is essentially the same as for any UTI: stay well hydrated, urinate regularly, and practice good hygiene. Women, who develop UTIs far more often than men due to anatomy, benefit from wiping front to back and urinating after sexual activity. Managing underlying conditions like diabetes also helps, since well-controlled blood sugar supports a stronger immune response.

In healthcare settings, prevention is more structured and more urgent. Strict hand hygiene by healthcare workers is one of the most effective measures against hospital-acquired infections, including Klebsiella UTIs.⁶ Catheter-associated UTIs account for a large share of hospital Klebsiella infections, so the single most effective strategy is minimizing catheter use. Hospitals have implemented catheter removal protocols, nurse-driven reminders to reassess catheter necessity daily, and guidelines that restrict insertion to situations where no alternative exists.

If you or a family member is hospitalized and has a urinary catheter, it is entirely reasonable to ask the medical team whether the catheter is still necessary. This is not being difficult; it is exactly the kind of question that infection-prevention programs encourage patients to ask. Every extra day a catheter stays in place increases the risk of a UTI, and healthcare teams sometimes lose track of catheters that were placed during an acute event and are no longer needed.

Klebsiella UTIs in Pregnancy

Pregnant women are at modestly increased risk for UTIs in general, and Klebsiella UTIs during pregnancy deserve extra attention because the treatment options are more limited. Many of the antibiotics effective against Klebsiella, including fluoroquinolones and trimethoprim-sulfamethoxazole during certain trimesters, are avoided in pregnancy due to potential harm to the developing baby. Nitrofurantoin can be used in certain trimesters but is also restricted near delivery. This leaves a narrower antibiotic window, and if the Klebsiella strain is resistant, the choices get narrower still.

Untreated or undertreated UTIs during pregnancy carry real risks, including preterm labor and low birth weight. Because of this, pregnant women are typically screened for bacteria in the urine even when they have no symptoms, a practice called screening for asymptomatic bacteriuria. If Klebsiella is found, treatment is warranted even without symptoms, because the risk of the infection progressing during pregnancy is higher than it would be in a non-pregnant adult.

When to Seek Care and What to Tell Your Doctor

If you have typical lower UTI symptoms (burning, frequency, urgency) and no fever or flank pain, your situation is probably uncomplicated and treatable with a short antibiotic course. But a few scenarios should prompt faster or more aggressive medical attention:

Fever or back pain: These suggest the infection may have reached the kidneys, which usually requires stronger antibiotics and sometimes hospitalization.
Recent hospitalization: If you were in the hospital or a long-term care facility within the past few months, mention it. Your doctor will want to consider resistant organisms, including Klebsiella, and may choose different empiric antibiotics.
Prior Klebsiella UTI: If you have had a Klebsiella UTI before, especially a resistant one, share the details. Past culture results can guide current treatment and prevent wasted time on antibiotics that will not work.
Catheter use: Current or recent catheter use raises the probability that Klebsiella or another hospital-associated organism is involved.
Diabetes or immune suppression: These conditions increase both the likelihood of Klebsiella and the risk of complications, so your doctor may want to monitor you more closely during treatment.

Providing a urine sample for culture before starting antibiotics is especially valuable when Klebsiella is a possibility. Many doctors prescribe empiric antibiotics for straightforward UTIs without a culture, which works fine most of the time because E. coli is predictable. But if the actual pathogen is a resistant Klebsiella strain, starting the wrong drug means days of continued symptoms and infection before switching to something effective. A culture takes one to two days to return results, but it gives your doctor a clear map of what will and will not work against your specific infection.